London
· Delayed Price · Currency is GBP · Price in USD OPKO Health Statistics
Total Valuation
OPKO Health has a market cap or net worth of GBP 822.74 million. The enterprise value is 913.03 million.
| Market Cap | 822.74M |
| Enterprise Value | 913.03M |
Important Dates
The next estimated earnings date is Thursday, February 27, 2025.
| Earnings Date | Feb 27, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -5.19% |
| Shares Change (QoQ) | +43.19% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 255.34M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | 35.40 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -9.15 |
| EV / Sales | 1.60 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -6.12 |
Financial Position
The company has a current ratio of 2.97, with a Debt / Equity ratio of 0.37.
| Current Ratio | 2.97 |
| Quick Ratio | 2.43 |
| Debt / Equity | 0.37 |
| Debt / EBITDA | n/a |
| Debt / FCF | -2.56 |
| Interest Coverage | -8.44 |
Financial Efficiency
Return on equity (ROE) is -9.39% and return on invested capital (ROIC) is -10.55%.
| Return on Equity (ROE) | -9.39% |
| Return on Assets (ROA) | -8.97% |
| Return on Invested Capital (ROIC) | -10.55% |
| Return on Capital Employed (ROCE) | -15.14% |
| Revenue Per Employee | 135,059 |
| Profits Per Employee | -25,389 |
| Employee Count | 3,930 |
| Asset Turnover | 0.33 |
| Inventory Turnover | 9.77 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +50.05% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +50.05% |
| 50-Day Moving Average | 1.53 |
| 200-Day Moving Average | 1.45 |
| Relative Strength Index (RSI) | 50.00 |
| Average Volume (20 Days) | 12,383 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 22.71 |
Income Statement
In the last 12 months, OPKO Health had revenue of GBP 530.78 million and -99.78 million in losses. Loss per share was -0.15.
| Revenue | 530.78M |
| Gross Profit | 62.95M |
| Operating Income | -230.90M |
| Pretax Income | -87.93M |
| Net Income | -99.78M |
| EBITDA | -156.20M |
| EBIT | -230.90M |
| Loss Per Share | -0.15 |
Balance Sheet
The company has 298.50 million in cash and 382.24 million in debt, giving a net cash position of -83.74 million.
| Cash & Cash Equivalents | 298.50M |
| Total Debt | 382.24M |
| Net Cash | -83.74M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 1.05B |
| Book Value Per Share | 1.53 |
| Working Capital | 311.85M |
Cash Flow
In the last 12 months, operating cash flow was -132.34 million and capital expenditures -16.88 million, giving a free cash flow of -149.21 million.
| Operating Cash Flow | -132.34M |
| Capital Expenditures | -16.88M |
| Free Cash Flow | -149.21M |
| FCF Per Share | n/a |
Margins
Gross margin is 11.86%, with operating and profit margins of -43.50% and -18.80%.
| Gross Margin | 11.86% |
| Operating Margin | -43.50% |
| Pretax Margin | -16.57% |
| Profit Margin | -18.80% |
| EBITDA Margin | -29.43% |
| EBIT Margin | -43.50% |
| FCF Margin | n/a |
Dividends & Yields
OPKO Health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 5.19% |
| Shareholder Yield | 5.19% |
| Earnings Yield | -12.13% |
| FCF Yield | -18.14% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
OPKO Health has an Altman Z-Score of -0.54. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -0.54 |
| Piotroski F-Score | n/a |